Indegene Limited — Financials & Forensics
Sector: Healthcare · NSE: INDGN · BSE: 544172 · ISIN: INE065X01017
17 Nov 2026
Add INDGN to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue from operations | ₹2,590 Cr | ₹2,839 Cr | ₹3,510 Cr |
| EBITDA | ₹505 Cr | ₹534 Cr | ₹619 Cr |
| EBITDA margin | 19.5% | 18.8% | 17.6% |
| Profit after tax | ₹337 Cr | ₹407 Cr | ₹401 Cr |
Deeper analysis
Recent filings by Indegene Limited
-
Analysts/Institutional Investor Meet/Con. Call Updates
06 Nov 2026 · General Update
-
Analysts/Institutional Investor Meet/Con. Call Updates
03 Nov 2026 · Financial Results
-
Transcript of the Q2 FY27 Earnings Call
03 Nov 2026 · Financial Results
-
Copy of Newspaper Publication
31 Oct 2026 · Regulatory Compliance
-
Analysts/Institutional Investor Meet/Con. Call Updates
30 Oct 2026 · General Update
Never miss a filing again
About Indegene Limited on Indian Stock Alerts
Indian Stock Alerts tracks Indegene Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.